Dr. Shokeen recently received an award from Siteman Cancer Center as a part of a $2.1 million dollar grant for cancer research. Along with Gregory Lanza, PhD, Dr. Shokeen will lead a research team to develop proof-of-concept evidence related to the therapeutic response and effectiveness of a new targeted combination nanotherapy for patients with multiple myeloma.